Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment

被引：2
|
作者：
Yurttutan, Sadik [1 ]
Gullu, Utku Ufuk [2 ]
Ipek, Sevcan [3 ]
机构：
[1] Kahramanmaras Sutcu Imam Univ, Div Neonatol, Dept Pediat, Fac Med, Avsar Campus, TR-46100 Kahramanmaras, Turkey
[2] Kahramanmaras Sutcu Imam Univ, Div Pediat Cardiol, Dept Pediat, Fac Med, Kahramanmaras, Turkey
[3] Kahramanmaras Sutcu Imam Univ, Div Pediat Intens Care Unit, Dept Pediat, Fac Med, Kahramanmaras, Turkey
来源：
INTERNAL AND EMERGENCY MEDICINE | 2021年 / 16卷 / 04期
关键词：
D O I：
10.1007/s11739-021-02663-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1101 / 1103
页数：3
相关论文
共 50 条
  • [21] Effect of tocilizumab on intensive care patients with Covid-19 pneumonia, a retrospective cohort study
    Pehlivanlar Kucuk, Mehtap
    Kucuk, Ahmet Oguzhan
    Pehlivanlar, Aysegul
    Ayaydin Murtezaoglu, Sevil
    Coban, Kadir
    Kilic, Gamze
    Aycicek, Olcay
    Oztuna, Funda
    Bulbul, Yilmaz
    Ozlu, Tevfik
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (01) : 39 - 49
  • [22] Treatment with Tocilizumab in Adult Patients with Moderate to Critical COVID-19 Pneumonia: A Single-Center Retrospective Study
    Radulescu, Amanda
    Istrate, Alexandru
    Muntean, Monica
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 117 : 1 - 7
  • [23] NIV IN MODERATE TO SEVERE ARDS DUE TO COVID-19 PNEUMONIA: A RETROSPECTIVE COHORT STUDY
    BOTSCH, A.
    ORAVEC, M.
    RAPIER, B.
    GOFF, L.
    DESMETT, A.
    CHEST, 2022, 161 (06) : 601A - 601A
  • [24] REMDESIVIR FOR MODERATE-TO-SEVERE COVID-19 PNEUMONIA IN MAINTENANCE DIALYSIS PATIENTS: A RETROSPECTIVE COHORT STUDY
    Gutierrez, Stephanie
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I691 - I692
  • [25] Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study
    Moreno-Perez, Oscar
    Andres, Mariano
    Leon-Ramirez, Jose-Manuel
    Sanchez-Paya, Jose
    Carlos Rodriguez, Juan
    Sanchez, Rosario
    Garcia-Sevila, Raquel
    Boix, Vicente
    Gil, Joan
    Merino, Esperanza
    JOURNAL OF AUTOIMMUNITY, 2020, 114
  • [26] Corticosteroids and tocilizumab reduce in-hospital mortality in severe COVID-19 pneumonia: a retrospective study in a Spanish hospital
    van den Eynde, E.
    Gasch, O.
    Oliva, J. C.
    Prieto, E.
    Calzado, S.
    Gomila, A.
    Machado, M. L.
    Falgueras, L.
    Ortonobes, S.
    Moron, A.
    Capilla, S.
    Navarro, G.
    Oristrell, J.
    Cervantes, M.
    Navarro, M.
    INFECTIOUS DISEASES, 2021, 53 (04) : 291 - 302
  • [27] A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia
    Yin Wang
    Weiwei Jiang
    Qi He
    Cheng Wang
    Baoju Wang
    Pan Zhou
    Nianguo Dong
    Qiaoxia Tong
    Signal Transduction and Targeted Therapy, 5
  • [28] A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia
    Wang, Yin
    Jiang, Weiwei
    He, Qi
    Wang, Cheng
    Wang, Baoju
    Zhou, Pan
    Dong, Nianguo
    Tong, Qiaoxia
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [29] Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
    Rosas, I. O.
    Brau, N.
    Waters, M.
    Go, R. C.
    Hunter, B. D.
    Bhagani, S.
    Skiest, D.
    Aziz, M. S.
    Cooper, N.
    Douglas, I. S.
    Savic, S.
    Youngstein, T.
    Del Sorbo, L.
    Gracian, A. Cubillo
    De la Zerda, D. J.
    Ustianowski, A.
    Bao, M.
    Dimonaco, S.
    Graham, E.
    Matharu, B.
    Spotswood, H.
    Tsai, L.
    Malhotra, A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (16): : 1503 - 1516
  • [30] Comparative evaluation of tocilizumab and itolizumab for treatment of severe COVID-19 in India: a retrospective cohort study
    Kumar, Abhyuday
    Kumar, Neeraj
    Pattanayak, Arunima
    Kumar, Ajeet
    Palavesam, Saravanan
    Nagaraju, Pradhan Manigowdanahundi
    Das, Rekha
    ACUTE AND CRITICAL CARE, 2024, 39 (02) : 234 - 242
12345